Assessment of the effects of pine bark extract supplementation on bone turnover and the possible mechanism through OPG/RANKL signaling in postmenopausal osteopenic women: A clinical trial protocol
Objective: Despite the high prevalence of osteopenia in post-menopausal women, its current treatments are controversial. The present study was designed to investigate the effect of pine bark extract on the bone turnover process and its possible mechanism through OPG/RANKL signaling in postmenopausal osteopenic women.
Methods: This randomized double-blind clinical trial will be conducted on postmenopausal osteopenic women in Shariati Hospital of Tehran University of Medical Sciences, Tehran, Iran. A total of 44 postmenopausal women with osteopenia will be randomly assigned to two study groups ─ one (n = 22) receiving a PBE supplement (250 mg/d) and one (n = 22) a placebo. Demographic characteristics and the past medical history (recorded measurements of bone turn-over markers, namely, PINP, BAP, CTx and OPG/RANKL) will be recorded before and after the intervention.
Ethics and dissemination: The research was performed after obtaining approval from the Ethics Committee of Tehran University of Medical Sciences (IR.TUMS.VCR.REC.1395.1408), in line with the Helsinki Declaration. Prior to the commencement of the study, a written informed consent form was signed and dated by participants and investigators. The results will be released at the right time.
Trial registration number: Pre-results, IRCT2015071123153N1
Discussion: This study will investigate the effect of pine bark extract supplementation on bone turnover in postmenopausal osteopenic women. The results may help practitioners to choose the better palliative treatment for osteopenic women.
Melton LJ, Chrischilles EA, Cooper C, Lane AW, Riggs BL. How many women have osteoporosis?. J BONE MINER RES. 2005; 20: 886-92.
El-Hajj Fuleihan G, Adib G, Nauroy L. The middle east & Africa regional audit, epidemiology, costs & burden of osteoporosis in 2011. International Osteoporosis Foundation. 2011:102011-5000.
Meybodi HA, Heshmat R, Maasoumi Z, Soltani A, Hossein-Nezhad A, Keshtkar AA, Bahrami A, Rajabian R, Nabipour I, Omrani GH, Pajouhi M. Iranian Osteoporosis Research Network: Background, mission and its role in osteoporosis management. IRAN J PUBLIC HEALTH. 2008; 37: 1-6.
Salehi I, Khazaeli S, Najafizadeh SR, Ashraf H, Malekpour M. High prevalence of low bone density in young Iranian healthy individuals. CLIN RHEUMATOL. 2009 Feb 1;28(2):173-7.
Son SM, Chun YN. Effect of oral therapy with alphacalcidol or calcium in Korean elderly women with osteopenia and low dietary calcium. NUTR RES. 2001; 21: 1347-55.
Sun Q, Zheng Y, Chen K, Yan W, Lu J, Dou J, Lv Z, Wang B, Gu W, Ba J, Mu Y. Osteopenia is associated with glycemic levels and blood pressure in Chinese postmenopausal women: a cross-sectional study. CLIN EXP MED. 2017; 17: 85-91.
Horcajada MN, Offord E. Naturally plant-derived compounds: role in bone anabolism. MOL PHARMACOL. 2012; 5: 205-18.
Đudarić L, Fužinac-Smojver A, Muhvić D, Giacometti J. The role of polyphenols on bone metabolism in osteoporosis. FOOD RES INT. 2015 Nov 30; 77: 290-8.
Takano T, Kozai Y, Kawamata R, Wakao H, Sakurai T, Kashima I. Inhibitory effect of maritime pine bark extract (Pycnogenol) on deterioration of bone structure in the distal femoral epiphysis of ovariectomized mice. ORAL RADIOL. 2011; 27:8–16
Mei L, Mochizuki M, Hasegawa N. Protective Effect of Pycnogenol® on Ovariectomy‐induced Bone Loss in Rats. PHYTOTHER RES. 2012; 26: 153-5.
Huang G, Wu J, Wang S, Wei Y, Chen F, Chen J, Shi J, Xia J. Pycnogenol® treatment inhibits bone mineral density loss and trabecular deterioration in ovariectomized rats. INT J CLIN EXP MED. 2015; 8: 10893.
Sugimoto H, Watanabe K, Toyama T, Takahashi SS, Sugiyama S, Lee MC, Hamada N. Inhibitory effects of French pine bark extract, pycnogenol®, on alveolar bone resorption and on the osteoclast differentiation. PHYTOTHER RES. 2015; 29: 251-9.
Hosseini S, Pishnamazi S, Sadrzadeh SM, Farid F, Farid R, Watson RR. 2001. Pycnogenol® in the management of asthma. J Med Food. 4: 201–209.
Packer L, Rimbach G, Virgili F. Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. FREE RADICAL BIO MED. 1999; 27:704-24.
Oliff H. Scientific and clinical monograph for Pycnogenol. The American Botanical Council. 2009.
Kim YJ, Kim YA, Yokozawa T. Pycnogenol modulates apoptosis by suppressing oxidative stress and inflammation in high glucose-treated renal tubular cells. FOOD CHEM TOXICOL. 2011; 49:2196-201.
Maimoona A, Naeem I, Saddiqe Z, Jameel K. A review on biological, nutraceutical and clinical aspects of French maritime pine bark extract. J ETHNOPHARMACOL. 2011; 133: 261-77.
Rohdewald PJ. Update on the clinical pharmacology of Pycnogenol (R). Medical Research Archives. 2015; 3: 1-1.
Mackinnon ES, Rao AV, Josse RG, Rao LG. Supplementation with the antioxidant lycopene significantly decreases oxidative stress parameters and the bone resorption marker N-telopeptide of type I collagen in postmenopausal women. OSTEOPOROSIS INT. 2011; 22: 1091-101.
Shen CL, Chyu MC, Yeh JK, Felton CK, Xu KT, Pence BC, Wang JS. Green tea polyphenols and Tai Chi for bone health: designing a placebo-controlled randomized trial. BMC MUSCULOSKEL DIS. 2009; 10: 110.
Sugiura M, Nakamura M, Ogawa K, Ikoma Y, Ando F, Shimokata H, Yano M. Dietary patterns of antioxidant vitamin and carotenoid intake associated with bone mineral density: findings from post-menopausal Japanese female subjects. OSTEOPOROSIS INT. 2011; 22: 143-52.
Dou C, Li J, Kang F, Cao Z, Yang X, Jiang H, Yang B, Xiang J, Xu J, Dong S. Dual effect of cyanidin on RANKL‐induced differentiation and fusion of osteoclasts. J CELL PHYSIOL. 2016; 231: 558-67.
Boyce BF, Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. ARCH BIOCHEM BIOPHYS. 2008; 473: 139-46.
Shen CL, Chyu MC, Yeh JK, Zhang Y, Pence BC, Felton CK, Brismée JM, Arjmandi BH, Doctolero S, Wang JS. Effect of green tea and Tai Chi on bone health in postmenopausal osteopenic women: a 6-month randomized placebo-controlled trial. OSTEOPOROSIS INT. 2012; 23: 1541-52.
|Issue||Vol 4, No 1 (Winter 2018)|
|Pine Bark Extract post-menopausal women osteopenia.|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|